Skip to content
Trial Eligibility
Menu

Bone Marrow Aspirate Concentrate (BMAC) vs Corticosteroid Injection

NCT05985785

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Prospective single-masked (study participant will be masked), randomized controlled trial to examine the influence of BMAC on patient-reported outcomes (PROs) in patients with primary knee osteoarthritis.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Osteoarthritis of the Knee

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 to 70 years
Sex
All
Healthy volunteers
Not accepted
Sponsor
Rush University Medical Center
Last updated on ClinicalTrials.gov
August 24, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Illinois · 1

  • Rush University Medical Center · Chicago, IL

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.